FDA Inspection
Dendreon Pharmaceuticals LLCDendreon Pharmaceuticals LLC – FDA Inspection, Oct 29, 2025
Record Details
This FDA Inspection record concerns Dendreon Pharmaceuticals LLC, with an inspection on October 29, 2025, issued by the Atlanta District Office, covering biologics.
View Company Profile
ID · 7b3579a1-1d37-40bc-8b3f-16301d44a749
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1286816
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.194(a)Complete test data included in records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dendreon Pharmaceuticals LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 21, 2022 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 22, 2018 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 1, 2016 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Dendreon Pharmaceuticals LLC
- FDA Inspection 1169722 - 2022-04-21
- FDA Inspection 1070321 - 2018-10-22
- FDA Inspection 1031496 - 2016-11-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.